Invention Grant
- Patent Title: Use of glycopyrrolate for treating tachycardia
-
Application No.: US15011582Application Date: 2016-01-31
-
Publication No.: US10695321B2Publication Date: 2020-06-30
- Inventor: Susan Snape , Robert Tansley
- Applicant: Heptares Therapeutics Limited
- Applicant Address: GB Cambridge
- Assignee: HEPTARES THERAPEUTICS LIMITED
- Current Assignee: HEPTARES THERAPEUTICS LIMITED
- Current Assignee Address: GB Cambridge
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@199357f4 com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@196a68bb
- Main IPC: A61K31/40
- IPC: A61K31/40 ; A61K31/167 ; A61K45/06 ; A61K9/00 ; A61M15/00 ; A61K31/4704
Abstract:
The invention relates to a novel use of the antimuscarinic agent glycopyrrolate, for example the salt glycopyrronium bromide. In particular, the invention relates to glycopyrrolate for use as a heart rate lowering agent and more particularly, but not exclusively, for use in patients suffering from respiratory conditions such as chronic obstructive pulmonary disease.
Public/Granted literature
- US20160143880A1 Use of Glycopyrrolate for Treating Tachycardia Public/Granted day:2016-05-26
Information query
